Dirk Witters News Today

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q2 2024 Earnings Call Transcript December 14, 2023 ImmunoPrecise Antibodies Ltd. beats earnings expectations. Reported EPS is $-0.07, expectations were $-0.09. Operator: Good morning, ladies and gentlemen. Thank you for joining us today for IPA’s Earnings Call covering the Second Quarter of Fiscal Year 2024. I am Sarah and I have […]

ImmunoPrecise Antibodies Ltd. , a leader in AI-driven biotherapeutic research and technology, is pleased to announce important Board of Director changes and upcoming financial reporting...

Report of Voting Results Submitted Pursuant to Section 11.3 of National Instrument 51-102 - Continuous Disclosure Obligations In accordance with...

Security Class Holder Account Number ------- Fold Form of...

IMMUNOPRECISE ANTIBODIES LTD. Unit 3204 - 4464 Markham Street Victoria, BC V8Z 7X8 NOTICE OF ANNUAL GENERAL MEETING OF...

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q1 2024 Earnings Call Transcript September 14, 2023 ImmunoPrecise Antibodies Ltd. misses on earnings expectations. Reported EPS is $0.11 EPS, expectations were $0.17. Operator: Good morning, ladies and gentlemen. Thank you for joining us today for IPA’s Earnings Call covering the First Quarter of Fiscal Year 2024. I am Julianne, and […]

VICTORIA, British Columbia--(BUSINESS WIRE)--Sep 14, 2023--

05.09.2023 - IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an advanced biotherapeutic research and technology company, is pleased to announce that further to its news release dated August 9, 2023, it has appointed, in its search for ... Seite 1